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Introduction
Hundreds of organophosphate (OP) compounds are cur-
rently available to use as insecticides [1]. OP insecticides
inhibit both cholinesterase and pseudocholinesterase activi-
ties [2], as they are irreversible cholinesterase inhibitors.
The inhibition of cholinesterase activity leads to accumula-
tion of acetylcholine at synapses, causing overstimulation
and disruption of neurotransmission in both central and
peripheral nervous systems [2]. Exaggerated manifestations
of nicotinic and muscarinic receptors appear as a result of
these actions [3]. OP insecticides are one of the most
important causes of poisoning in Turkey, as in many devel-
oping countries [4]. The mode of exposure to OP insecti-
cides varies, including dermal, gastrointestinal, inhalational
OP = organophosphate.
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Abstract
Introduction  Organophosphate (OP) insecticides inhibit both acetylcholinesterase and pseudo-
cholinesterase activities. The clinical course of OP poisoning may be quite severe and may need
intensive care management. We report our experience with the intensive care management of serious
OP insecticide poisonings.
Methods A retrospective study was performed on the patients with OP poisoning followed at our
medical intensive care unit. Forty-seven patients were included. Diagnosis was performed from the
history taken either from the patient or from the patient’s relatives regarding the agent involved in the
exposure. Intravenous atropine and pralidoxime was administered as soon as possible. Pralidoxime
could not be given to 16 patients: 2 patients did not receive pralidoxime because they were late
admissions, and 14 did not receive pralidoxime because the Ministry of Health office was out of
stock. Data are presented as mean ± standard deviation.
Results There were 25 female and 22 male patients. Thirty-two (68%) were suicide attempts and 15
(32%) were accidental exposure patients. The mortality rates for the patients who did and did not
receive pralidoxime were 32 and 18.7%, respectively and were not statistically different. Ten patients
(21.2%) required mechanical ventilation. The mortality rate for the patients who required mechanical
ventilation was 50%, but the rate was 21.6% for those patients who were not mechanically
ventilated. Intermediate syndrome was been observed in 9 (19.1%) patients. Complications were
observed in 35 (74.4%) patients. The duration of the intensive care stay was 5.2 ± 3.0 days.
Conclusion  OP insecticide poisoning is a serious condition that requires rapid diagnosis and
treatment. Because respiratory failure is the major reason for mortality, careful monitoring, appropriate
management and early recognition of this complication may decrease the mortality rate among these
patients.
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Received: 11 September 2000
Revisions requested: 7 November 2000
Revisions received: 2 February 2001
Accepted: 15 April 2001
Published: 31 May 2001
Critical Care 2001, 5:211–215
This article is online at http://ccforum.com/content/5/4/211
© 2001 Sungur and Güven, licensee BioMed Central Ltd
(Print ISSN 1364-8535; Online ISSN 1466-609X)Critical Care    August 2001 Vol 5 No 4 Sungur and Güven
and intravenous routes [2,5,6]. Poisoning occurs as a
result of agricultural use, accidental exposure, suicide and,
rarely, homicide [2,7,8]. The mortality rate of OP poisoning
is high: fatal issue is often related to a delay in diagnosis
or an improper management. Early diagnosis and appro-
priate treatment, conversely, are often life saving, although
the clinical course of OP poisonings might be quite severe
and necessitate intensive care management. In this article,
we report our experience with the intensive care manage-
ment of serious OP insecticide poisonings.
Methods
A retrospective study was conducted on patients with OP
poisoning admitted to our nine-bed medical intensive care
unit between January 1990 and January 2000. Forty-
seven patients were included. The diagnosis was based
on information taken either from the patient or from the
patient’s family about the agent involved in the exposure.
We could not confirm the diagnosis by measuring plasma
or red blood cell anticholinesterase levels since these are
not measured in our hospital. Toxlab screening of the
patients was also not performed because it is not available
at our institution. Treatment was implemented as soon as
the diagnosis of OP insecticide poisoning was suspected.
Atropine and/or pralidoxime sulfate was administered.
Atropine is given either as a continuous infusion or inter-
mittent dosing. Continuous infusion was started as
0.02–0.08 mg/kg per hour until control of hypersecretion
occurred. Heart rates exceeding 130 beats/min were
avoided using intravenous diltiazem or propranolol for
myocardial protection. Intermittent dosing was performed
using 2 mg atropine every 15 min until secretions were
controlled. Heart rate and pupil size were not used as
indices as long as the heart rate was above 60 beats/min.
Atropine was discontinued 24 hours after all signs of
atropinisation occurred and drying of secretions was
achieved. Pralidoxime sulfate was administered as 4 g
daily divided to four doses for every patient as long as
available. We obtained pralidoxime from the offices of the
Ministry of Health in Kayseri. Pralidoxime is prescribed to
the patient’s relatives and they receive it from these offices
free of charge. Pralidoxime is unfortunately sometimes not
available at these offices.
Blood gas and routine biochemistry were performed daily.
Gastric lavage followed by administration of activated
charcoal via nasogastric tube, and cleansing of the
patient’s body with soap and water was started. The
patients were admitted to the intensive care unit based on
the severity of the clinical signs and symptoms. The indica-
tions for endotracheal intubation and mechanical ventila-
tion were as follows: excessive secretions; a depressed
level of consciousness, which causes an inability to
protect the airway; poor gas exchange, which was un-
responsive to oxygen treatment; cardiorespiratory arrest;
and severe metabolic acidosis with hemodynamic instabil-
ity (systolic blood pressure <90 mmHg). Synchronized
intermittent mandatory ventilation + pressure support
mode in either pressure-controlled or volume-controlled
form was started. The positive end expiratory pressure
was initially applied as 5 cmH2O and then titrated to keep
SaO2 above 94% with 40% FIO2. Weaning from mechani-
cal ventilation was carried out with pressure support
weaning and T-tube trials. The chi-square test was used
for statistical analysis. Data are presented as mean ± stan-
dard deviation.
Results
During the study period, 47 patients who had OP poison-
ing with a known agent were admitted to the medical inten-
sive care unit. There were 25 female and 22 male patients.
The mean age was 30 ± 15 years when admitted to the
medical intensive care unit of a 600-bed university hospital.
Thirty-two (68%) patients were suicide attempts and 15
(32%) were accidental exposure. Forty-four (93.6%) of the
patients were poisoned through the gastrointestinal route.
One (2.1%) patient had inhalational poisoning and two
(4.2%) patients had intravenous injection for suicidal pur-
poses. There were 10 different types of OP insecticide
agents involved (Table 1). The estimated average time for
the admission to the emergency department after the expo-
sure was 9.4 hours (range, 1–96 hours). The most frequent
clinical signs were meiosis, change in mental status, hyper-
salivation, agitation and fasciculations (Table 2).
All of the patients received atropine. Atropine was admin-
istered during 3.4 ± 2.1 days and the average total
atropine dose was 79.1 ± 62.9 mg. A total of 31 (66%)
patients received pralidoxime. Pralidoxime was given for
1.9 ± 1.4 days and the average dose was 3.5 ± 3.0 g.
Pralidoxime was not administered to 16 (34%) patients.
The mortality rate among patients treated with pralidoxime
was 32.0% (10 patients), but the rate was 18.7%
(3 patients) for patients not treated with pralidoxime
(P > 0.05). Thirty-seven of the patients (78.7%) were
exposed to OP with moderate toxicity (LD50 >500 mg/kg),
9 patients (19.1%) to OP with high toxicity (LD50
<50 mg/kg) and 1 patient to an agent with low toxicity
(LD50 >1000 mg/kg). Nine patients died in the moderate
toxicity group and four patients died in the high toxicity
group (P > 0.05). Mechanical ventilatory support was
needed for 10 (21.2%) patients. Average arterial blood
gas values of these patients were as follows: pH 7.26
(range, 6.93–7.45); pCO2, 40.2 mmHg (range,
22–53 mmHg); pO2, 68.2 mmHg (range, 50–91 mmHg);
HCO3, 14.2 mmol/l (range, 10–25 mmol/l); SaO2, 87.5%
(range, 78–95%). The duration of mechanical ventilation
was 4.1 ± 3.2 days. The mortality rate for the patients who
were mechanically ventilated was 50% (5 patients),
although the mortality rate was 27.6% (13 patients) for all
patients. The mortality rate for the mechanically ventilated
patients was not statistically different compared withr
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those patients not mechanically ventilated. Two patients
who are mechanically ventilated died with sudden car-
diorespiratory arrest following ventricular tachycardia, and
three died from pneumonia and complicating adult respira-
tory distress syndrome. Intermediate syndrome has been
observed in 9 (19.1%) of the patients: 4 of these patients
required mechanical ventilation, and 3 of them could not
be weaned from the mechanical ventilator and died. Three
patients with intermediate syndrome who were not
mechanically ventilated died due to delay for endotracheal
intubation. The reasons for mortality for the other patients
who died before intubation were as follows: one failure to
intubate, and sudden respiratory and cardiac arrest (asys-
tole) in four patients. Abnormal laboratory values were ele-
vated liver enzymes, elevated lactate dehyrogenase,
elevated blood glucose and leukocytosis (Table 3). Com-
plications were observed in 35 (74.4%) patients: respira-
tory failure (14 patients), aspiration pneumonia (10
patients), urinary system infection (6 patients), convulsion
(4 patients) and septic shock (1 patient). The duration of
the intensive care stay was 5.2 ± 3.0 days.
Discussion
OP compounds are used worldwide in agriculture as well
as in household gardens [9]. This easy availability of the
compounds has resulted in a gradual increase in acciden-
tal and suicidal poisoning, mainly in developing countries
[10]. Ingestion of OP in an attempt at suicide is a major
problem, especially for developing countries, probably
because of the wide availability of pesticides as result of
extensive use in agriculture and because of sale of these
items over the counter in these countries [1]. OP poison-
ing due to suicidal attempt accounts for at least 40–60%
of all cases in some African countries [10,11]. In this
study, our rate of suicidal poisoning is 68%, probably
because of the uncontrolled sale and use of these agents
all over the country.
The inhibition of cholinesterase activity leads to the accu-
mulation of acetylcholine at synapses, causing overstimu-
lation of both central and peripheral nervous systems.
Exposure to OP will interfere with synaptic transmission
peripherally at muscarinic receptors and nicotinic recep-
tors. Nicotinic manifestations include increased or
decreased muscle power and skeletal muscle fascicula-
tions. Muscarinic manifestations include excessive saliva-
tion, meiosis and diarrhea. The most frequent signs are
reported to be meiosis, vomiting, hypersalivation, respira-
tory distress, abdominal pain, and depressed level of con-
sciousness and muscle fasciculation [10]. In the present
case series, the most frequent signs were meiosis, a
depressed level of consciousness, hypersalivation, agita-
tion and fasciculations.
Hyperglycemia has been reported many times in the litera-
ture [10,12,13], and we also observed mild hyperglycemia
in 15 patients. The increase in serum glucose is believed
to be due to secondary release of catecholamines from
the adrenal medulla [14]. We observed 11 patients that
had abnormal aspartate aminotransferase levels, which is
reported very rarely [15]. OP compounds contain many
solvents that may cause this effect. High lactate dehydro-
genase levels may be associated with oxidative tissue
damage induced by OP insecticides [16], and this level
was high in 15 of our patients. Leukocytosis, which we
observed in 34 patients, both with and without a left shift
has been reported many times [10,14,17].
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Table 1
Organophosphate insecticide agents responsible for the
poisonings
Agent Number of patients
Dichlorvos 24 (51.1%)
Ethyl-Parathion 5 (10.6%)
Fenthion 4 (8.5%)
Chlorpyrifos 3 (6.3%)
Azinphos-methyl 3 (6.3%)
Diazinon 3 (6.3%)
Methamidophos 2 (4.2%)
Ethion 1 (2.1%)
Malathion 1 (2.1%)
Dictrophos 1 (2.1%)
Total 47 (100%)
Table 2
Clinical signs and symptoms of the patients
Sign or symptom Number of patients
Meiosis 37 (78%)
Depressed mental status 36 (76%)
Hypersalivation 31 (66%)
Agitation 26 (55%)
Fasciculation 23 (49%)
Tachycardia 12 (25%)
Nausea 12 (25%)
Bradicardia 11 (23%)
Muscle weakness 9 (19%)
Vomiting 7 (15%)
Diarrhea 5 (10%)
Midriasis 3 (6%)Pralidoxime could not be given to 14 of the total patients
since the Ministry of Health offices were out of prali-
doxime. Pralidoxime was not given to two patients
because they were admitted to the hospital 48 and 96
hours after OP poisoning, which was assessed as delayed
time for pralidoxime administration. These two patients
were treated successfully with atropine alone. OP com-
pounds either have two ethyl ester or two methyl ester
groups. Reactivation of dimethyl phosphorylated acetyl-
cholinesterase proceeds quite rapidly and may improve
without oxime therapy, although reactivation of diethyl
phosphorylated acetylcolinesterase does not occur unless
significant amounts of oximes are used. Two patients who
died and did not receive pralidoxime were exposed to
dichlorvos, which has two methyl ester groups. One
patient who died and did not receive pralidoxime was
exposed to parathion, which has one ethyl ester group.
The major pharmacological action of oximes such as prali-
doxime and obidoxime is to reactivate acetyl
cholinesterase by removal of the phosphate group bound
to the esteratic site [18]. Oximes should be given as soon
as possible before aging takes place, but it is reported
that there is beneficial response as long as 24 hours after
exposure [9]. Oximes are believed to be effective, and to
be especially useful in treating moderate or severe OP
poisoning [2]. Oximes may also reverse the central
nervous system effects of OP [2].
There has been only one placebo-controlled trial regard-
ing oxime treatment for OP poisonings [19], which
showed that pralidoxime + atropine does not have any
benefit over atropine alone in OP poisonings. The need
for mechanical ventilation, median days on mechanical
ventilation, median days in the intensive care unit, fre-
quency of the intermediate syndrome and the mortality
rate are reported to be similar in each group [19]. In the
present study, we observed that mortality is not signifi-
cantly different whether or not the patients are treated
with pralidoxime sulfate. This observation is also con-
firmed by the study of De Silva et al [19] but, since the
data is still limited, we strongly suggest using pralidoxime.
This issue needs further controlled studies. Our mortality
rate (27.6%) is higher compared with series reported for
OP insecticide poisoning and intensive care management
[18,19]. In these two studies [18,19], the mortality rates
were reported to be 12 and 16%, respectively. Our
patients were admitted to the hospital 9.4 hours later
than the exposure, and this relatively delayed admission
might be a factor for the high mortality rate of our cases.
We should implement a well-programmed emergency
medical system that we currently do not have, and edu-
cation of the general practitioners regarding intoxications
needs to be improved.
Intermediate syndrome is a state of muscle paralysis that
occurs after recovery from cholinergic crisis but before
the expected onset of the delayed polyneuropath, and
probably results from post-synaptic neuromuscular junc-
tion dysfunction [20]. Patients with intermediate syn-
drome require optimal respiratory management, atropine
and pralidoxime. Three patients with intermediate syn-
drome did not receive pralidoxime and two of these
patients eventually died. The rate of intermediate syn-
drome of our cases was 19.1%, with 4 of the patients
intubated and mechanically ventilated, but 3 patients
could not be weaned from the mechanical ventilator and
died. Three of the cases with intermediate syndrome died
due to delay for endotracheal intubation. After these
events, we increased the nurse to patient ratio and the
number of the residents in the unit because it was
obvious that these cases had severe respiratory distress
requiring endotracheal intubation before they died.
The mean respiratory rate increased from
22 ± 6 breaths/min to 38 ± 8 breaths/min, which is an
obvious sign of respiratory failure, during the last 6 hours of
hospitalisation. It has been reported previously that pro-
longed respiratory support and difficult weaning may be a
consequence of intermediate syndrome [11]. Patients with
intermediate syndrome may be followed with oxygen
support without intubation and mechanical ventilation, but
hypoxia and signs of respiratory failure such as tachypnea,
paradoxical respiration and vigorous use of accessory respi-
ratory muscles should be followed closely. Observation of
any of these signs by an intensive care physician must lead
to an assessment of the patient for endotracheal intubation
and mechanical ventilation. The mortality rate was 50% for
the patients who were mechanically ventilated, although it
was 21.6% for the patients who are not mechanically venti-
lated and the difference is not statistically important
(P > 0.05). The most troublesome complication was respira-
tory failure, which was observed in 29.7% (14) of our
patients. Three of these patients died due to delay for endo-
tracheal intubation. Four of our patients died due to sudden
respiratory and cardiac arrest, which may be the first indica-
tion of unsuspected or incipient respiratory failure. Patients
with OP poisoning may have respiratory failure for many
reasons, including aspiration of gastric contents, excessive
secretions, pneumonia and septicemia complicating adult
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Table 3
Abnormal laboratory findings of the patients
Normal values Patient values
Aspartate aminotransferase (U/l) 0–50 53.7 ± 84.3
Lactate dehydrogenase (U/l) 225–450 548.8 ± 45.5
White blood cell count 4000–10,000 13,857 ± 7040
Blood glucose (mg/dl) 70–110 131 ± 61.9respiratory distress syndrome [21]. Aspiration pneumonia is
another troublesome complication, and careful monitoring
during transport and early recognition of an absent gag
reflex may reduce the incidence of aspiration pneumonia.
Early recognition of respiratory failure, prompt endotracheal
intubation and mechanical ventilation are life-saving mea-
sures in severe OP poisoning.
In conclusion, OP insecticide poisoning is a serious condi-
tion that needs rapid diagnosis and treatment. Since respi-
ratory failure is the major reason for mortality, careful
monitoring, appropriate management and early recognition
of this complication may decrease the mortality rate
among these patients.
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